Wilke H - Search Results

1

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.

Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ, Buente H. Preusser P, et al. Among authors: wilke h. J Clin Oncol. 1989 Sep;7(9):1310-7. doi: 10.1200/JCO.1989.7.9.1310. J Clin Oncol. 1989. PMID: 2671287 Clinical Trial.

2

Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.

Wilke H, Preusser P, Stahl M, Harstrick A, Meyer HJ, Achterrath W, Schmoll HJ, Seeber S. Wilke H, et al. Cancer Chemother Pharmacol. 1991;29(1):83-4. doi: 10.1007/BF00686342. Cancer Chemother Pharmacol. 1991. PMID: 1742854

3

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ, Meyer J, Siewert JR, Achterrath W, Lenaz L, Knipp H, et al. Wilke H, et al. J Clin Oncol. 1989 Sep;7(9):1318-26. doi: 10.1200/JCO.1989.7.9.1318. J Clin Oncol. 1989. PMID: 2769330

4

Etoposide and split-dose cisplatin in small-cell lung cancer.

Wilke H, Achterrath W, Schmoll HJ, Gunzer U, Preusser P, Lenaz L. Wilke H, et al. Am J Clin Oncol. 1988 Oct;11(5):572-8. doi: 10.1097/00000421-198810000-00013. Am J Clin Oncol. 1988. PMID: 2845770

5

Chemotherapy of gastric cancer.

Preusser P, Achterrath W, Wilke H, Lenaz L, Fink U, Heinicke A, Meyer J, Bunte H. Preusser P, et al. Among authors: wilke h. Cancer Treat Rev. 1988 Dec;15(4):257-77. doi: 10.1016/0305-7372(88)90025-4. Cancer Treat Rev. 1988. PMID: 3071419 Review. No abstract available.

6

Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin.

Preusser P, Wilke H, Achterrath W, Neuhaus B, Balleisen L, Meyer J, Van de Loo J. Preusser P, et al. Among authors: wilke h. Anticancer Res. 1986 Sep-Oct;6(5):1195-6. Anticancer Res. 1986. PMID: 3800325

7

5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus.

Stahl M, Wilke H, Meyer HJ, Preusser P, Berns T, Fink U, Achterrath W, Knipp H, Harstrick A, Berger M, et al. Stahl M, et al. Among authors: wilke h. Eur J Cancer. 1994;30A(3):325-8. doi: 10.1016/0959-8049(94)90250-x. Eur J Cancer. 1994. PMID: 8204353 Clinical Trial.

8

Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: results of a phase II study.

Klaassen U, Wilke H, Harstrick A, Philippou Pari C, Strumberg D, Neumann K, Eberhardt W, Achterrath W, Lenaz L, Seeber S. Klaassen U, et al. Among authors: wilke h. Ann Oncol. 1998 Jan;9(1):45-50. doi: 10.1023/a:1008292332166. Ann Oncol. 1998. PMID: 9541682 Free article. Clinical Trial.

9

Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancer.

Vanhoefer U, Harstrick A, Köhne CH, Achterrath W, Rustum YM, Seeber S, Wilke H. Vanhoefer U, et al. Among authors: wilke h. J Clin Oncol. 1999 Mar;17(3):907-13. doi: 10.1200/JCO.1999.17.3.907. J Clin Oncol. 1999. PMID: 10071283 Clinical Trial.

10

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Stahl M, et al. Among authors: wilke h. J Clin Oncol. 2005 Apr 1;23(10):2310-7. doi: 10.1200/JCO.2005.00.034. J Clin Oncol. 2005. PMID: 15800321 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters